A detailed history of Perkins Coie Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Perkins Coie Trust CO holds 5,914 shares of LLY stock, worth $4.71 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
5,914
Previous 5,758 2.71%
Holding current value
$4.71 Million
Previous $5.21 Million 0.5%
% of portfolio
1.2%
Previous 1.25%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$772.14 - $960.02 $120,453 - $149,763
156 Added 2.71%
5,914 $5.24 Million
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $951,754 - $1.19 Million
1,313 Added 29.54%
5,758 $5.21 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $338,146 - $452,391
571 Added 14.74%
4,445 $3.46 Million
Q4 2023

Jan 09, 2024

BUY
$525.19 - $619.13 $1.78 Million - $2.1 Million
3,390 Added 700.41%
3,874 $2.26 Million
Q3 2023

Oct 11, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 Added 6.61%
484 $259,000
Q3 2021

Oct 13, 2021

SELL
$221.6 - $272.71 $62,934 - $77,449
-284 Reduced 38.48%
454 $105,000
Q2 2021

Jul 14, 2021

SELL
$180.55 - $233.54 $34,485 - $44,606
-191 Reduced 20.56%
738 $169,000
Q1 2021

Apr 13, 2021

SELL
$164.32 - $212.72 $52,582 - $68,070
-320 Reduced 25.62%
929 $174,000
Q4 2020

Jan 12, 2021

SELL
$130.46 - $172.63 $48,139 - $63,700
-369 Reduced 22.81%
1,249 $211,000
Q3 2020

Oct 13, 2020

SELL
$146.22 - $169.13 $58,488 - $67,652
-400 Reduced 19.82%
1,618 $239,000
Q2 2020

Jul 13, 2020

SELL
$136.42 - $164.18 $54,567 - $65,672
-400 Reduced 16.54%
2,018 $331,000
Q1 2020

Apr 10, 2020

BUY
$119.05 - $147.35 $49,524 - $61,297
416 Added 20.78%
2,418 $335,000
Q2 2019

Jul 10, 2019

BUY
$110.79 - $129.32 $44,316 - $51,728
400 Added 24.97%
2,002 $222,000
Q3 2017

Oct 13, 2017

BUY
$77.07 - $85.54 $123,466 - $137,035
1,602
1,602 $137,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Perkins Coie Trust CO Portfolio

Follow Perkins Coie Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.